Take Part

Research advertised below is provided as a service to the diabetes research community. This research is not specifically endorsed by Diabetes Australia.

All studies and surveys that are promoted on the Diabetes Australia website and social media channels are reviewed by the Medical Education and Scientific Council (MESC). If you would like to promote a survey or ask for participants, email [email protected].

---

The Flash Study Evaluation

Seeking healthcare professionals to participate

This study aims to identify the barriers and enablers to the use of continuous glucose monitors by Aboriginal and Torres Strait Islander peoples with type 2 diabetes, and to determine pathways to overcome these barriers.

Participation involves one 45-minute semi-structured interview, which will be conducted in-person or online at your preferred time/day. We are seeking healthcare professionals experienced in providing care for Aboriginal and Torres Strait Islander peoples with type 2 diabetes who use continuous glucose monitors.

Please contact [email protected] for further information.

---

Wellbeing and type 1 diabetes

Seeking young people with type 1 diabetes

We understand that living with type 1 diabetes can impact a young person’s mental health due to the ongoing demands of management. In this program, we want to support you to develop helpful coping skills and boost your resilience. 

We are seeking young people aged 13-17 years who have been living with type 1 diabetes for at least 6 months to receive an online mental health and wellbeing program; designed by and for teens with type 1 diabetes.

For more information, or to complete the expression of interest, visit: www.thekids.org.au/projects/psychosocial-intervention-type-1-diabetes/

You can contact the team at The Kids Research Institute at [email protected] or on +61 493 702 900.

---

Diabetes prediction study

The PREDICTION study is looking for participants to help to understand more about diabetes and how to prevent diabetes complications.

To apply for this study, you must:

• have type 1 or type 2 diabetes
• have been diagnosed after 2016
• have been between 15 and 40 when diagnosed.

Study participants can do most of what is required for the study from the comfort of their own home.

Once selected for the study, you will be asked to attend a local private pathology clinic (at our cost) to get your blood and urine samples collected, and get your blood pressure measured at your local pharmacy.

If you are interested in participating or would like further information, visit baker.edu.au/prediction.

You can contact the study team on (03) 8532 1826 or email [email protected].

---

Help improve preventive health care for people with intellectual disability

This study wants to make health action planning better for people with intellectual disability.

What is this study about?

People with intellectual disability can have poor health. This project wants to make it easy for people with intellectual disability to engage in health action planning with their doctor to take care of their
preventive health. (e.g., dietary changes, specialist referrals, screening procedures, blood tests).

Through our partnership with key groups, this study will communicate with people with intellectual disability, their support networks (paid and non-paid) and health professionals to improve health action planning for people with intellectual disability. We want to learn from the experiences of health care professionals who have provided preventive health care to people with intellectual disability.

What will happen if you take part

We will ask to you come to an interview or group meeting (called a focus group). We will ask you questions in person, online or on the phone to learn about your experiences. We can communicate with you in a different way if you prefer. The meeting will take about 1 to 2 hours.

You will receive a $50 gift card for your participation.

Your experiences will be used to help us improve preventive health care for people with intellectual disability.

If you have questions, or want to join the study, contact Jack Cooper at [email protected] or on +61 434 182 259.

---

Physical activity and exercise timing in Type 1 Diabetes: Is there a better time to exercise?

This study aims to better understand the role of physical activity on blood glucose in people with type 1 diabetes.

We are looking to recruit adults between 18 and 64 years of age, who have been diagnosed with type 1 diabetes at least 6 months ago.

This study aims to better understand:

• how the timing of physical activity can influence glucose control and risk of nocturnal hyper glycaemia
• the relationship between physical activity and glucose control
• attitudes, behaviours and barriers to physical activity in people with type 1 diabetes.

The questionnaire consists of 46 questions and is expected to take 20-30 minutes to complete. You can complete in one sitting or return to the survey – your link is active for 48 hours.

At the end of the survey, you may be invited to complete some additional information. This is completely voluntary and you may choose to provide further information or not.

Start the survey.

For more information contact Nicky Copper at [email protected].

---

Type 2 diabetes and persistent pain

The University of Sydney are currently recruiting participants with type 2 diabetes and persistent pain for a new clinical trial. This trial will test a new online intervention developed to improve pain severity and pain interference. 

The study involves completing 4 x 10-15 minute online training sessions over two weeks, as well as some pre and post-intervention surveys. This study will take a maximum of 2.5 hours across a 3-month period. 

Your participation will help contribute to diabetes research, and we will donate $5 to Diabetes Australia for each person who completes this study.  

To learn more and get involved, visit the link here – https://bit.ly/cbmi-diabetes – or email the research team at [email protected]  

---

Paratus Clinical – type 2 diabetes and weight loss

This clinical trial looks to investigate type 2 diabetes and weight loss. Learn more at www.paratusclinical.com

If you have difficulty managing your type 2 diabetes whilst on Metformin, and have not had any weight loss medications recently, you might be eligible for a new clinical trial.

Eligible participants will visit the clinic up to 12 times with an additional 8 phone visits over approximately 16 months (69 weeks).  Once enrolled in the clinical trial, participants will be randomly allocated to receive either the study medicine or Tirzepatide, the comparator. All treatments will be administered by an injection into a fold of skin on the stomach, thigh or upper arm once weekly.

This clinical trial is sponsored by Novo Nordisk.

---

Dietary quality, lifestyle and health among Australian adults

This project aims to explore the relationships between dietary habits and other health related factors such as demographic and mental health.

You are eligible if you are 18 years or over and live in Australia. This study is not for you if you are pregnant or breastfeeding.

Phase 1 – an online survey that takes approximately 40 – 60 minutes to compete on each of the three occasions over 12 months.

Phase 2 (optional) – one off in-person assessment at the University of Newcastle (Callaghan campus).

All phase 1 participants completing both surveys will be entered into the draw to win one of five $100 gift vouchers at each of the three occasions.

To complete the online survey visit: https://redcap.hmri.org.au/surveys/?s=C8KNYXHTA9ALLJPA

Reach out to the study team at [email protected]

---

Study: A clinical research study for people with excess weight and heart disease

TRIUMPH-Outcomes is a clinical research study for people with excess weight who
also have heart disease or kidney disease, or both.

You may be able to join this research study if you:

• have a BMI of 27 kg/m2 or more
• are aged 45 years or older
• have at least one of the following:
  ○ heart disease
  ○ kidney disease
  ○ type 2 diabetes or not, and your HbA1c levels are equal to or less than 10 percent (86 mmol/mol).

TRIUMPH-3 is a clinical research study for people with excess weight and heart disease.
The study will test how safe and well the investigational medicine (the medicine being
studied) works for weight management.

You may be able to join the research study if you:

• Are aged 18 years or older
• Have obesity, with a BMI of 35 or higher
• Have heart disease
• Have not been able to lose body weight on your own.

For more information contact Northern Beaches Clinical Research on:
Ph: 1300 55 96 76
Email: [email protected]

---

Study: Understanding the experience of diabetic peripheral neuropathy and potential
treatment to improve the sense of touch.

Medical professionals with extensive experience and knowledge of treating individuals with diabetic
peripheral neuropathy wanted for an interview study investigating the needs and experiences of those living with peripheral neuropathy and to document your opinions of a conceptual device to improve the sense of touch. The study can provide insights to inform the development of new treatments or technologies using a patient-centred approach that facilitates patient engagement and empowers the voices of those with real lived experience.

Eligibility requirements:

• Medical professionals who have extensive experience and knowledge of treating individuals with
  diabetic peripheral neuropathy.
• Five years or more working directly with patients with diabetic peripheral neuropathy.
• Be willing to speak in depth with researchers about your experience of working with individuals
  with diabetic peripheral neuropathy.
• Be willing to provide your opinion of a conceptual device to improve the sense of touch.

Duration: 1 hour

You will receive a $30 e-voucher per hour for participation.

Where: Western Sydney University (Westmead Campus) or remotely via Zoom.

All aspects of the study are confidential. You will not be identified from any data collected. Results of the experiment will be reported in journal articles and conference papers, but no individual data will be presented.

Your participation in this study is voluntary. You may withdraw from the study at any time; you do not need to give a reason and there will be no consequences for doing so.

This project has Western Sydney University HREC ethics approval MA03199.

To participate scan the QR code below or email Prof. Paul Breen for more information.

Email: [email protected]

To complete the survey visit: https://surveyswesternsydney.au1.qualtrics.com/jfe/form/SV_50B5fxa1rWi2EUC?Q_CHL=qr

---

Study: Understanding the experience of diabetic peripheral neuropathy and potential treatment to
improve the sense of touch.

Adults with diabetic peripheral neuropathy wanted for an interview study investigating the experiences of living with peripheral neuropathy and to document your opinions of a conceptual device to improve the sense of touch. The study can provide insights to inform the development of new treatments or technologies using a patient-centred approach that facilitates patient engagement and empowers the voices of those with real lived experience.

Eligibility requirements:

• Have peripheral neuropathy (numbness/loss of feeling in hands and feet) as a result of diabetes mellitus.
• Be an adult over the age of 18.
• Be willing to provide your opinions of a conceptual device to improve the sense of touch.
• Be willing to speak in depth with researchers about your experiences of diabetic peripheral neuropathy.

Exclusion criteria:

• If you have history of severe psychiatric disorder.
• If you have neuropathy due to other causes, including, but not limited to, autoimmune disorders, inflammatory neuropathies (including acute or chronic inflammatory demyelinating polyneuropathy), thyroid disease or endocrine disorders other than diabetes, heavy metal or chemical-agent exposures, nutritional deficiency, metabolic disorders, vasculitis, heredity, infections, injury, or paraneoplastic syndromes.
• If you have previously had any amputation.
• Current active diabetic foot uclers.
• Not ambulatory (participants who used a cane or walkers were allowed).

Duration: 1 hour

You will receive a $30 e-voucher per hour for participation.

Where: Western Sydney University (Westmead Campus) or remotely via Zoom.

All aspects of the study are confidential. You will not be identified from any data collected. Results of the experiment will be reported in journal articles and conference papers, but no individual data will be presented.

Your participation in this study is voluntary. You may withdraw from the study at any time; you do not need to give a reason and there will be no consequences for doing so.

To participate in the study visit the study survey: https://surveyswesternsydney.au1.qualtrics.com/jfe/form/SV_bkr2K3I7HquKdAa?Q_CHL=qr

Or for more information email Prof. Paul Breen: [email protected]

This project has Western Sydney University HREC ethics approval MA03199.

---

What does diabetes support look like to you?

Co-design of a digital health intervention for people with type 2 diabetes in the Australian setting 

RMIT University, Monash University and Parkside Specialists.  

We want to understand your views on a healthy lifestyle behaviour program for managing type 2 diabetes.  

If you fit the following criteria, take our short anonymous survey and tell us what diabetes support means to you. 

• Adults aged 18+ 
• Australian resident 
• Diagnosed with type 2 diabetes 
• Or carer/family member of people living with type 2 diabetes 

Potential benefits:

• A chance to win 1 of 5 Gro Health mobile application membership to help be your best you 
• By sharing your experiences, insights, and perspectives, you can help improve and develop more effective, patient-centered healthcare interventions and programs. 

The survey may take 10 minutes and requires you to access it via this link: Survey Community Engagement Study

---

Bone-muscle interaction in patients with type 2 diabetes & the effects of exercise

Victoria University and Australian Institute for Musculoskeletal Science

Do you have type 2 diabetes?

Seeking male and female volunteers over the age of 18 with type 2 diabetes to participate in a study examining the effects of exercise on bone-muscle-fat interaction and its relationship to health and function.

What’s involved?

Participants will be randomised to exercise training (cycling) or control (usual activities).

Assessments include:

•  Aerobic fitness and strength Blood and urine samples
•  Mobility Glucose tolerance testing
•  Questionnaires Fat and muscle samples (optional)
•  Bone and muscle scans

Where is it?

Victoria University, Footscray Park

What’s in it for me?

Reimbursement. You may receive gift cards up to $100 value.

Some participant exclusions may include:

•  Warfarin or Vit K medications
•  Current smoker or quit in the past 12 months
•  BMI over 40

To see if you can get involved, contact:

Email Rhiannon Healy: [email protected]

---

Understanding mobile health intervention needs of Australians living with type 2 diabetes

University of Southern Queensland

Are you interested in participating in a study to identify the key features of mobile health apps to improve self-management of type 2 diabetes? 

Are You  

• Over 18 years old  
• Living with type 2 diabetes  
• Able to complete a survey online  
• English speaking  
• Smart phone/mobile device user.  

Potential Benefits  

Participating in this study will help us to identify and understand the advanced features needed in a mobile health app to improve self-management of Type 2 Diabetes. 

Participation involves completing an online survey that takes 15 – 30 minutes.

Start the survey

---

Developing a model of preventive health care for people with intellectual disability

We are doing a research study on having good health. We want to hear from people with intellectual disability, their support networks and health professionals.

If you are interested:

Contact: Bela Laginha

Email: [email protected]

Phone: +61 2 9348 0190

HREC Approval Number: HC220517 – August 2022

---

Cardiovascular study for women

Are you female, aged 40 – 65 years, and want to reduce your risk of heart disease?

And you have had a history of:

• Diabetes during pregnancy (gestational diabetes) or
• High blood pressure or pre-eclampsia during pregnancy or
• Early menopause (under the age of 44 years) or
• Are of Aboriginal / Torres Strait Islander background (aged 35 – 65 years).

You could be eligible for the CAC-Women’s Trial.

This is a large national study of 6 months duration with all women receiving a free specialised CT scan of the heart arteries.

To find out more, submit your enquiry by sending your email address and mobile phone number to: [email protected]

This research project has been approved by the Western Sydney Local Human Research Ethics Committee – dated 22 April 2022.

---

The MothersBabies Study

Are you interested in groundbreaking pre-pregnancy research?

UNSW’s Microbiome Research Centre is looking at the impact of gestational diabetes in previous pregnancies, as well as how your pre-pregnancy lifestyle (diet, exercise, medications, pre-existing medical conditions) could affect your microbiome.

How do I get involved?

If you’d like to sign up, or see if you are eligible, fill out the form available at www.unsw.to/mothersbabies. If you’d like to chat more information or to a researcher, please email [email protected].

Research Approvals

HREC Approval: 2019/ETH00192

ANZCTR Number: ACTRN12619000800123

Australian Breastfeeding Association Research Approval: 2020-4

---

A new, investigational procedure to help manage blood glucose levels in individuals living with type 2 diabetes

Are you looking for a new way to help manage your Type 2 Diabetes?

The REGENT-1 clinical study is evaluating a new, non-surgical, endoscopic treatment (called the Endogenex procedure) that may interest you.

During an Endogenex procedure, a small flexible camera (endoscope) is used to guide a special device through the mouth and past the stomach into the first portion of the small intestine called the duodenum. This device applies therapy to the surface of the duodenum which initiates the regeneration or regrowth of healthy cells that help the body manage blood glucose levels.

Because the Endogenex procedure is done endoscopically, this means there will be no incisions (cuts or scars). Patients will go home the same day and normal physical activity can usually be resumed the next day.

You may be eligible to be included in the study if you:

• Are between 18 and 70 years of age
• Have been diagnosed with type 2 diabetes
• Have a BMI of 24-40 kg/m²
• Have HbA1C of 7.5-11.0%
• Are taking medication to help manage blood glucose levels
• Do not take any steroids, blood-thinners, anti-coagulation medications (eg. warfarin), weight loss medications, or non-steroidal anti-inflammatory drugs that cannot be stopped for one month
• Have not had any previous gastrointestinal surgery that has changed your anatomy (eg. gastric bypass, gastric band or gastric sleeve surgery)
• Do not have any autoimmune disease (excluding Graves’ or Hashimoto’s disease, with adequately replaced thyroid hormones)
• Do not suffer from irritable bowel syndrome (IBS) or inflammatory bowel disease (eg. Crohn’s disease, coeliac)
• Do not consume excessive alcohol
• No pregnant or plan to be pregnant in next year
• Meet all eligibility criteria as assessed by your study doctor

Please visit our website (bmiclinic.com.au/regent) for more information.

---

‘Stepping up’ exercise for type 2 diabetes: A stepped care approach to lifestyle therapy

This research project aims to examine the effects of an adaptive exercise approach to improving health for individuals with Type 2 Diabetes. We are specifically examining the effect of adapting an exercise program on blood glucose management, abdominal fat, and cardiorespiratory health.

• Are you between 25-69 years of age?
• Have you been diagnosed with Type 2 Diabetes?
• Do you have a waist circumference >80cm (women) or >94cm (men)?
• Are you willing to complete regular supervised and/or unsupervised exercise sessions?
• Are you willing to participate in assessments of physical health and lifestyle behaviours?
• Are you willing to wear a wrist-based activity tracker for the duration of the study?

For this trial, you will be randomized (like the toss of a coin) into one of two groups. The first group will be required to complete a minimum of 150 minutes of exercise, which includes a home exercise program. The second group will receive exercise and nutritional advice. At regular time-points, you will be required to attend health assessments to assess your response to the intervention at the Charles Perkins Centre (Camperdown). Your exercise program may be adjusted throughout trial depending on your assessment results. The duration of your trial participation will vary (8 months minimum, 12 months maximum).

This study is being conducted at the University of Sydney Charles Perkins Centre (John Hopkins Dr, Camperdown, NSW, 2006) in conjunction with the University of Queensland.

This study has been approved by the NSW Sydney Local Health District (Royal Prince Alfred Hospital Zone).

Ethics approval number: X21-0016.

For any questions, or to express interest in participating, please contact:

Alex Armstrong ([email protected])

---

Type1Screen

Type1Screen is an Australian initiative offering free type 1 diabetes risk screening.

The aim of Type1Screen is to identify people at risk of developing type 1 diabetes as early in the disease process as possible before symptoms develop. To be eligible for Type1Screen, individuals must be aged over 2 years and have a family history of type 1 diabetes.

How do I get involved?

Participation involves a blood test either at a local pathology collection centre or via a test which can be sent to, and done in, the home. Registration is available directly online. Register now.

The blood sample goes to a lab in Melbourne and results are sent back within 8 weeks of sample receipt.

Those who are found to be antibody-positive will be supported through a national network of diabetes centres and offered further testing to determine their risk of developing diabetes. They will also be offered the opportunity to enter any available prevention studies through the Australasian Type 1 diabetes Immunotherapy Collaborative (ATIC).

Further information about Type1Screen is available at the Type1Screen website or by following their Facebook or Instagram pages @type1screen. For further information email the team at [email protected].

---

Do you have Type 2 diabetes and foot nerve damage?

People with Type 2 Diabetes may develop foot nerve damage (peripheral neuropathy), as a complication. Symptoms might include: numbness of the feet; coldness in the legs; tingling or pins and needles in the feet; burning pain in the feet and legs. Peripheral neuropathy can affect balance and walking, and increase the risk of falling. Researchers at The University of Queensland are seeking participants for a trial of different shoe insoles which may improve balance, walking and foot sensation in adults with Type 2 diabetes and peripheral neuropathy.

I’m interested, what would be involved?

You would be given a pair of shoe insoles to wear for 4 weeks. Across 2 sessions we will measure the feeling in your feet, standing balance, and walking ability whilst barefoot, wearing shoes, and 2 different insoles (textured and smooth). You will be required to wear a small wireless activity monitor for 2 weeks, and complete 3 short surveys relating to your general health, diabetes, foot health, falls, and experience wearing the insoles.

Am I eligible to take part?

To be eligible to participate in this trial you MUST: – be aged 18 years or older – have Type 2 diabetes and peripheral neuropathy – live in South East Queensland – be able to walk over 20 metres with/without an aid (e.g. walking stick) – be willing to wear shoe insoles for 4 weeks

There are some medical conditions that would make you ineligible to take part. Please contact the lead researcher, Dr Anna Hatton, to find out more (see below).

What will I receive for taking part?

Participants will be remunerated for their transport to and from The University of Queensland (St Lucia campus) for assessments, by way of return taxi fares (within the Brisbane region) or day car parking.

To register your interest to take part, please follow the survey link below: https://www.surveymonkey.com/r/GKCMFJJ

I would like to know more: Please contact Dr Anna Hatton on: (Tel) 07 3365 4590 or (Email) [email protected]

---

Type 1 Diabetes TrialNet

Find out if your family is at risk and help your community

What is TrialNet?

TrialNet is a global program to screen relatives of people with type 1 diabetes. This trial can help you and your family find out your risk of developing type 1 diabetes, allowing for early treatment. Your participation will also help determine how to prevent type 1 diabetes.

Get peace of mind and help prevent diabetes.

TrialNet is dedicated to the study, prevention, and early treatment of type 1 diabetes. It works with more than 200 screening sites throughout Australia, the United States, Canada, Finland, United Kingdom, Italy and New Zealand. TrialNet is supported by the National Institutes of Health, which is part of the United States Federal Government. It is also supported by Diabetes Australia, JDRF Australia and major diabetes organisations in other countries.

Find out more: www.diabetestrialnet.org

---

Clinical Trials Connect

Clinical Trials Connect (CTC) was established in 2008. CTC is an online participant recruitment website designed to help match members of the Australian community to research opportunities Australia wide, and deliver recruitment solutions to researchers.

People can register their interest to participate in trials on the website either as a healthy volunteer or as a patient with an existing medical condition.

Click for more information